A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

Journal: Journal of Experimental Medicine

Published: 2019-12-02

DOI: 10.1084/jem.20190147

Affiliations: 34

Authors: 60

Go to article
Institutions Share
IRCCS Bambino Gesù Children's Hospital, Italy 0.36
Institute for Biochemistry and Molecular Biology II, HHU, Germany 0.08
Department of Pediatrics, BCM, United States of America (USA) 0.07
San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Italy 0.06
National Rare Diseases Centre (CNMR), ISS, Italy 0.04
Department of Pediatrics, CU, United States of America (USA) 0.04
Department of Molecular and Human Genetics, BCM, United States of America (USA) 0.03
Department of Oncology and Molecular Medicine, ISS, Italy 0.03
Department of Systems Medicine, University of Rome Tor Vergata, Italy 0.03
Karolinska University Hospital, Sweden 0.03
Human Genome Sequencing Center (HGSC), BCM, United States of America (USA) 0.03
Baylor-John Hopkins Center for Mendelian Genomics (BHCMG), United States of America (USA) 0.02
Oslo University Hospital (OUS), Norway 0.02
Astrid Lindgren Children's Hospital, Sweden 0.02
IRCCS Policlinico San Matteo, Italy 0.02
Department of Bioengineering, Rice University, United States of America (USA) 0.02
National Institute of Health (ISS), Italy 0.02
Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Germany 0.02
Medical Scientist Training Program, BCM, United States of America (USA) 0.01
Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy 0.01
Sapienza University of Rome, Italy 0.01
San Raffaele Scientific Institute, Italy 0.01
UiO Institute of Clinical Medicine (Klinmed), Norway 0.01
Department of Clinical Science (K2), UIB, Norway 0.01
Broegelmann Research Laboratory, UIB, Norway 0.01
Department of Women's and Children's Health (KBH), KI, Sweden 0.01
Vita-Salute San Raffaele University (UniSR), Italy 0.01